Geode Capital Management
BDSX icon

Geode Capital Management’s Biodesix BDSX Stock Holding History

Geode Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
67,657
+17,659
+35% +$262K ﹤0.01% 3251
2026
Q1 		$726K Buy
49,998
+7,545
+18% +$93.5K ﹤0.01% 3461
2025
Q4 		$289K Buy
42,453
+2,235
+6% +$16.5K ﹤0.01% 3788
2025
Q3 		$304K Buy
40,218
+2,674
+7% +$20.6K ﹤0.01% 3793
2025
Q2 		$212K Sell
37,544
-4,517
-11% -$36.5K ﹤0.01% 3856
2025
Q1 		$526K Buy
42,061
+701
+2% +$13.5K ﹤0.01% 3523
2024
Q4 		$1.27M Buy
41,360
+1,131
+3% +$33.3K ﹤0.01% 3275
2024
Q3 		$1.43M Buy
40,229
+13,536
+51% +$466K ﹤0.01% 3230
2024
Q2 		$817K Buy
26,693
+7,436
+39% +$212K ﹤0.01% 3386
2024
Q1 		$551K Buy
19,257
+1,401
+8% +$47.9K ﹤0.01% 3576
2023
Q4 		$657K Buy
17,856
+3,937
+28% +$124K ﹤0.01% 3511
2023
Q3 		$459K Sell
13,919
-4,559
-25% -$127K ﹤0.01% 3631
2023
Q2 		$455K Buy
18,478
+6,730
+57% +$202K ﹤0.01% 3678
2023
Q1 		$437K Buy
11,748
+5,442
+86% +$223K ﹤0.01% 3691
2022
Q4 		$290K Buy
6,306
+102
+2% +$2.77K ﹤0.01% 3908
2022
Q3 		$157K Buy
6,204
+1,365
+28% +$52.6K ﹤0.01% 4342
2022
Q2 		$158K Sell
4,839
-4,137
-46% -$134K ﹤0.01% 4391
2022
Q1 		$303K Buy
8,976
+929
+12% +$60.7K ﹤0.01% 4178
2021
Q4 		$851K Buy
8,047
+496
+7% +$64.8K ﹤0.01% 3784
2021
Q3 		$1.24M Buy
7,551
+253
+3% +$48K ﹤0.01% 3572
2021
Q2 		$1.93M Buy
7,298
+3,545
+94% +$1.11M ﹤0.01% 3277
2021
Q1 		$1.52M Buy
3,753
+1,501
+67% +$670K ﹤0.01% 3386
2020
Q4 		$907K Buy
+2,252
New +$701K ﹤0.01% 3393

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Geode Capital Management's BDSX Position: Q2 2026 in Review

Geode Capital Management increased its Biodesix (BDSX) stake by 35% in Q2 2026, buying an estimated $262K and bringing the position to 67,657 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3251.

Geode Capital Management first reported a position in BDSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.93M in Q2 2021. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Geode Capital Management held 67,657 shares of Biodesix worth $1.53M as of Q2 2026.
  • Geode Capital Management bought 17,659 Biodesix shares in Q2 2026, an estimated $262K.
  • Biodesix made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3251 holding.
  • Geode Capital Management first reported a position in Biodesix in Q4 2020 and has held it in 23 quarters since.
  • Geode Capital Management's Biodesix position peaked at $1.93M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.